Clinical Trial Update: Irinotecan and Celecoxib in Treating Patients With Unresectable or Metastatic Colorectal Cancer [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating irinotecan in combination with celecoxib for unresectable or metastatic colorectal cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Celecoxib (Celecoxib)
• Irinotecan (Irinotecan)

Snippet

Sponsor: Roswell Park Cancer Institute | Conditions: Colorectal Cancer, Diarrhea | Phase 1 | Status: COMPLETED